IPAR vs SRPT · P/E 17, rev $1.32B vs rev $1.90B
Inter Parfums Inc (IPAR) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Inter Parfums Inc (IPAR) is a household & personal products company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported IPAR revenue for 2023-12-31 was $1.32B. Net income was $187.8M. Revenue was up 21.3% from 2022-12-31 to 2023-12-31. IPAR currently screens at market cap $2.92B and trailing P/E 17.3.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
IPAR currently screens at market cap $2.92B and trailing P/E 17.3. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the IPAR and SRPT stock pages for the full models.
Not investment advice.